These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28855524)

  • 1. RNAi combining Sleeping Beauty transposon system inhibits ex vivo expression of foot-and-mouth disease virus VP1 in transgenic sheep cells.
    Deng S; Li G; Yu K; Tian X; Wang F; Li W; Jiang W; Ji P; Han H; Fu J; Zhang X; Zhang J; Liu Y; Lian Z; Liu G
    Sci Rep; 2017 Aug; 7(1):10065. PubMed ID: 28855524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tongue Epithelium Cells from shRNA Mediated Transgenic Goat Show High Resistance to Foot and Mouth Disease Virus.
    Li W; Wang K; Kang S; Deng S; Han H; Lian L; Lian Z
    Sci Rep; 2015 Dec; 5():17897. PubMed ID: 26671568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region.
    Lv K; Guo Y; Zhang Y; Wang K; Li K; Zhu Y; Sun S
    Res Vet Sci; 2009 Jun; 86(3):443-52. PubMed ID: 19062053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine fetal epithelium cells expressing shRNA targeting viral VP1 gene resisted against foot-and-mouth disease virus.
    Wang H; Liu X; Wu J; Wu G; Yu L; He C; Yang H; Xie W; Xia X; He H
    Virology; 2013 May; 439(2):115-21. PubMed ID: 23481248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells.
    Li X; Wang J; Liu J; Li Z; Wang Y; Xue Y; Li X; Cao H; Zheng SJ
    Vet Microbiol; 2013 Sep; 166(1-2):35-46. PubMed ID: 23764275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenically mediated shRNAs targeting conserved regions of foot-and-mouth disease virus provide heritable resistance in porcine cell lines and suckling mice.
    Jiao Y; Gong X; Du J; Liu M; Guo X; Chen L; Miao W; Jin T; Chang H; Zeng Y; Zheng Z
    Vet Res; 2013 Jul; 44(1):47. PubMed ID: 23822604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice.
    Chen W; Yan W; Du Q; Fei L; Liu M; Ni Z; Sheng Z; Zheng Z
    J Virol; 2004 Jul; 78(13):6900-7. PubMed ID: 15194766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of short hairpin RNA targeting foot-and-mouth disease virus with transgenic bovine fetal epithelium cells.
    Wang H; Wu J; Liu X; He H; Ding F; Yang H; Cheng L; Liu W; Zhong J; Dai Y; Li G; He C; Yu L; Li J
    PLoS One; 2012; 7(8):e42356. PubMed ID: 22905125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of eukaryotic expression vector containing foot-and-mouth disease virus VP1 gene and its expression in dendritic cells].
    Li J; Wang R; Shi W; Bian HX; Zhang L; Zhang L; Wang JX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Sep; 25(9):802-4. PubMed ID: 19737465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. shRNA transgenic swine display resistance to infection with the foot-and-mouth disease virus.
    Hu W; Zheng H; Li Q; Wang Y; Liu X; Hu X; Liu W; Liu S; Chen Z; Feng W; Cai X; Li N
    Sci Rep; 2021 Aug; 11(1):16377. PubMed ID: 34385528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of the foot-and-mouth disease virus internal ribosomal entry site by targeting relatively conserved region among serotypes.
    Matsui T; Handa Y; Kanda T; Tsukiyama-Kohara K
    Virus Genes; 2019 Dec; 55(6):786-794. PubMed ID: 31367998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-vectored shRNAs targeted to the highly conserved regions of VP1 and 2B in tandem inhibits replication of foot-and-mouth disease virus both in vitro and in vivo.
    Xu YF; Shen HY; Zhao MQ; Chen LJ; Li YG; Liao M; Jia JT; Lv YR; Yi L; Chen JD
    J Virol Methods; 2012 Apr; 181(1):51-8. PubMed ID: 22327142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mouse model integrating siRNA targeting the foot and mouth disease virus.
    Pengyan W; Jianjun J; Ning L; Jinliang S; Yan R; Chuangfu C; Zhiru G
    Antiviral Res; 2010 Aug; 87(2):265-8. PubMed ID: 20176056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection.
    Hu S; Qiao J; Fu Q; Chen C; Ni W; Wujiafu S; Ma S; Zhang H; Sheng J; Wang P; Wang D; Huang J; Cao L; Ouyang H
    Elife; 2015 Jun; 4():e06951. PubMed ID: 26090904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VP1 S154D mutation of type Asia1 foot-and-mouth disease virus enhances viral replication and pathogenicity.
    Lian K; Yang F; Zhu Z; Cao W; Jin Y; Liu H; Li D; Zhang K; Guo J; Liu X; Zheng H
    Infect Genet Evol; 2016 Apr; 39():113-119. PubMed ID: 26792712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amber codon is genetically unstable in generation of premature termination codon (PTC)-harbouring Foot-and-mouth disease virus (FMDV) via genetic code expansion.
    Hao R; Ma K; Ru Y; Li D; Song G; Lu B; Liu H; Li Y; Zhang J; Wu C; Zhang G; Hu H; Luo J; Zheng H
    RNA Biol; 2021 Dec; 18(12):2330-2341. PubMed ID: 33849391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Foot-and-Mouth Disease Virus VP1 protein using a replication-competent recombinant canine adenovirus type 2 elicits a humoral antibody response in a porcine model.
    Liu Y; Hu R; Zhang S; Zhang F; Li Z; Wei X; Chen L
    Viral Immunol; 2006; 19(2):202-9. PubMed ID: 16817763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation.
    Ekanayaka P; Lee SY; Herath TUB; Kim JH; Kim TH; Lee H; Chathuranga K; Chathuranga WAG; Park JH; Lee JS
    PLoS Pathog; 2020 Nov; 16(11):e1009057. PubMed ID: 33232374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.